In light of the fact that protein hydrolysates have insulinotropic effect in T2D patients and stimulate GLP-1 secretion in the isolated colon from rats and L-cell lines, we hypothesized that small peptides, such as di- or tripeptides from protein hydrolysates may be useful for treatment T2D. The gene discussed is GLP1R; the disease is type 2 diabetes mellitus.